Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Organ-specific autoimmunity: a 1986 overview.

G F Bottazzo, I Todd, R Mirakian

    Immunological Reviews
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction: Mediterranean diet, selenium and Graves' ophthalmopathy: a prospective, randomized, single-center study.

    Endocrine·2025
    Same author

    Mediterranean diet, selenium and Graves' ophthalmopathy: a prospective, randomized, single-center study.

    Endocrine·2025
    Same author

    Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Very low serum IGF-1 levels are associated with vertebral fractures in adult males with beta-thalassemia major.

    Journal of endocrinological investigation·2024
    Same author

    Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.

    Journal of endocrinological investigation·2024
    Same author

    Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.

    Breast cancer research : BCR·2023
    Same journal

    Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.

    Immunological reviews·2026
    Same journal

    Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure.

    Immunological reviews·2026
    Same journal

    The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity.

    Immunological reviews·2026
    Same journal

    Tissue-Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation.

    Immunological reviews·2026
    Same journal

    Rethinking Immunity in Tissues: The Biology of Tertiary Lymphoid Structures.

    Immunological reviews·2026
    Same journal

    Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity.

    Immunological reviews·2026
    See all related articles

    Autoimmune diseases involve complex immune system dysregulation. Aberrant HLA Class II expression on target cells may drive organ-specific autoimmunity, potentially explaining varied disease presentations and guiding new therapies.

    Area of Science:

    • Immunology
    • Pathogenesis
    • Autoimmunity

    Background:

    • The immune system has intricate regulatory networks.
    • Autoimmune diseases present complex pathogenic pictures.
    • Effector mechanisms in organ-specific autoimmunity cause disease symptoms.

    Purpose of the Study:

    • Describe effector mechanisms in organ-specific autoimmunity.
    • Explore factors contributing to autoimmune disease development.
    • Investigate aberrant HLA Class II expression in autoimmunity.

    Main Methods:

    • Review of effector mechanisms in organ-specific autoimmunity.
    • Discussion of potential pathogenic factors, including idiotypic interactions.
    • Detailed examination of aberrant HLA Class II molecule expression by target cells.

    Related Experiment Videos

    Main Results:

    • Effector mechanisms can be cytotoxic, stimulatory, or blocking.
    • Evidence links autoantibodies to diseases like Type I diabetes and infant diarrhea.
    • Aberrant HLA Class II expression on target cells is a key focus for pathogenesis.

    Conclusions:

    • Understanding autoimmune disease complexity is crucial for targeted therapies.
    • Aberrant HLA Class II expression may initiate or promote autoimmunity.
    • Regulation of HLA Class II expression could explain disease heterogeneity.